The effect on trust is two fold. First we should look at tust in SI and MSB. This over the last few months has been restored or at least heading in the right direction. The other side is trust in the FDA, I see this turning, the distrust at the time of the CRL was very much the driver of the SP yet now we can see why the FDA did what they did and in the longer term there actions will result in a far better trial results. So the distrust was way over the top. At the same time the FDA lost trust in the broarder market, this would have had significants to all biotechs.
The effect on trust is two fold. First we should look at tust in...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
-0.015(1.41%) |
Mkt cap ! $1.198B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.09 | $1.05 | $4.232M | 3.978M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 61694 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.06 | 45910 | 3 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.06 |
Change
-0.015 ( 0.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.09 | $1.05 | 969435 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| MSB (ASX) Chart |